| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 759289 | 88315 | ACENOCUMAROL AUROVITAS 4 MG COMPRIMIDOS EFG | ACENOCUMAROL AUROVITAS 4 MG COMPRIMIDOS EFG, 20 comprimidos | 4 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88315/88315_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88315/88315_p.pdf | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2022-11-25 | 1 | 1 | 1 | 2022-11-26 | 2022-11-25 | 1 | 2026-02-25 | View Edit Delete | ||||||||||||
| 759164 | 88271 | FULVESTRANT EUGIA 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG | FULVESTRANT EUGIA 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG, 1 jeringa + 1 aguja | 250 mg inyectable 5 ml | 33 | 1 | 61 | 1 jeringa + 1 aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88271/88271_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88271/88271_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2022-12-12 | 1 | 1 | 1 | 2022-12-12 | 2022-12-12 | 1 | 2023-06-15 | View Edit Delete | ||||||||||||
| 759165 | 88271 | FULVESTRANT EUGIA 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG | FULVESTRANT EUGIA 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG, 2 jeringas + 2 agujas | 250 mg inyectable 5 ml | 33 | 2 | 61 | 2 jeringas + 2 agujas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88271/88271_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88271/88271_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2022-12-12 | 1 | 1 | 1 | 2022-12-12 | 2022-12-12 | 1 | 2023-06-15 | View Edit Delete | ||||||||||||
| 759855 | 1211620003 | SAPROPTERINA DIPHARMA 100 MG POLVO PARA SOLUCION ORAL EFG | SAPROPTERINA DIPHARMA 100 MG POLVO PARA SOLUCION ORAL EFG, 30 sobres | 100 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211620003/1211620003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211620003/1211620003_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40888 | AUROVITAS SPAIN, S.A.U. | 2022-12-22 | 1 | 1 | 1 | 2022-12-23 | 2022-12-22 | 1 | 2023-06-15 | View Edit Delete | ||||||||||||
| 759856 | 1211620004 | SAPROPTERINA DIPHARMA 500 MG POLVO PARA SOLUCION ORAL EFG | SAPROPTERINA DIPHARMA 500 MG POLVO PARA SOLUCION ORAL EFG, 30 sobres | 500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211620004/1211620004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211620004/1211620004_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40888 | AUROVITAS SPAIN, S.A.U. | 2022-12-22 | 1 | 1 | 1 | 2022-12-23 | 2022-12-22 | 1 | 2023-07-05 | View Edit Delete | ||||||||||||
| 758105 | 87928 | BENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | BENDAMUSTINA AUROVITAS 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mg | 100 mg | 45 | 5 | 34 | 5 viales de 100 mg | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87928/87928_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87928/87928_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2022-07-29 | 1 | 1 | 1 | 2022-07-29 | 2022-07-29 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 759673 | 88361 | CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CABAZITAXEL AUROVIT 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 3 ml | 60 mg inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88361/88361_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88361/88361_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2022-12-09 | 1 | 1 | 1 | 2022-12-10 | 2022-12-09 | 1 | 2023-01-23 | View Edit Delete | ||||||||||||
| 759676 | 72635 | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DOCETAXEL AUROVITAS 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 8 ml | 20 mg/ml inyectable 8 ml | 45 | 1 | 34 | 1 vial de 8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72635/72635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72635/72635_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2011-01-10 | 1 | 1 | 1 | 2011-01-10 | 2022-12-02 | 1 | 2023-09-20 | View Edit Delete | ||||||||||||
| 760591 | 88445 | AMBRISENTAN AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMBRISENTAN AUROVITAS 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88445/88445_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88445/88445_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-03-15 | 1 | 1 | 1 | 2023-03-15 | 2023-03-15 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 760596 | 88446 | AMBRISENTAN AUROVITAS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AMBRISENTAN AUROVITAS 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88446/88446_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88446/88446_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-03-15 | 1 | 1 | 1 | 2023-03-15 | 2023-03-15 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762016 | 88609 | ESLICARBAZEPINA ACETATO AUROVITAS 800 MG COMPRIMIDOS EFG | ESLICARBAZEPINA ACETATO AUROVITAS 800 MG COMPRIMIDOS EFG, 30 comprimidos | 800 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88609/88609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88609/88609_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-02-08 | 1 | 1 | 1 | 2023-02-09 | 2023-02-08 | 0 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762017 | 88609 | ESLICARBAZEPINA ACETATO AUROVITAS 800 MG COMPRIMIDOS EFG | ESLICARBAZEPINA ACETATO AUROVITAS 800 MG COMPRIMIDOS EFG, 60 comprimidos | 800 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88609/88609_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88609/88609_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-02-08 | 1 | 1 | 1 | 2023-02-09 | 2023-02-08 | 0 | 2026-02-25 | View Edit Delete | ||||||||||||
| 762536 | 88793 | GLICLAZIDA AUROVITAS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | GLICLAZIDA AUROVITAS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 comprimidos | 30 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88793/88793_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88793/88793_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-04-17 | 1 | 1 | 1 | 2023-04-18 | 2023-04-17 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762537 | 88794 | GLICLAZIDA AUROVITAS 60 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | GLICLAZIDA AUROVITAS 60 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 comprimidos | 60 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88794/88794_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88794/88794_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-04-17 | 1 | 1 | 1 | 2023-04-18 | 2023-04-17 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762670 | 88815 | MANIDIPINO AUROVITAS 10 MG COMPRIMIDOS EFG | MANIDIPINO AUROVITAS 10 MG COMPRIMIDOS EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88815/88815_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88815/88815_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-04-27 | 1 | 1 | 1 | 2023-04-28 | 2023-04-27 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762671 | 88816 | MANIDIPINO AUROVITAS 20 MG COMPRIMIDOS EFG | MANIDIPINO AUROVITAS 20 MG COMPRIMIDOS EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88816/88816_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88816/88816_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-04-27 | 1 | 1 | 1 | 2023-04-28 | 2023-04-27 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762956 | 88915 | SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88915/88915_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88915/88915_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-06-19 | 1 | 1 | 1 | 2023-06-20 | 2023-06-19 | 1 | 2024-03-13 | View Edit Delete | ||||||||||||
| 761871 | 88574 | OXALIPLATINO AUROVIT 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO AUROVIT 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88574/88574_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88574/88574_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2023-01-27 | 1 | 1 | 1 | 2023-01-28 | 2023-01-27 | 0 | 2024-09-17 | View Edit Delete | ||||||||||||
| 761872 | 88574 | OXALIPLATINO AUROVIT 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO AUROVIT 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 40 ml | 5 mg/ml inyectable perfusión 40 ml | 45 | 1 | 34 | 1 vial de 40 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88574/88574_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88574/88574_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2023-01-27 | 1 | 1 | 1 | 2023-01-28 | 2023-01-27 | 0 | 2024-09-17 | View Edit Delete | ||||||||||||
| 762322 | 88690 | AZACITIDINA EUGIA 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG | AZACITIDINA EUGIA 25 MG/ML POLVO PARA SUSPENSION INYECTABLE EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88690/88690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88690/88690_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2023-02-24 | 1 | 1 | 1 | 2023-02-25 | 2023-02-24 | 1 | 2024-03-01 | View Edit Delete |
Page 224 of 1036, showing 20 records out of 20702 total, starting on record 4461, ending on 4480